[{"id":"9ee14615-2219-4b64-beee-b0a3fb7501ed","acronym":"","url":"https://clinicaltrials.gov/study/NCT00571662","created_at":"2021-02-17T12:52:43.145Z","updated_at":"2024-07-02T16:35:31.868Z","phase":"Phase 2","brief_title":"Safety and Efficacy of Pentostatin and Low Dose TBI With Allogenic Peripheral Blood Stem Cell Transplant","source_id_and_acronym":"NCT00571662","lead_sponsor":"University of Nebraska","biomarkers":" HLA-B","pipe":"","alterations":" ","tags":["HLA-B"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclosporin A microemulsion • pentostatin • Leukine (sargramostim)"],"overall_status":"Completed","enrollment":" Enrollment 76","initiation":"Initiation: 12/08/2000","start_date":" 12/08/2000","primary_txt":" Primary completion: 12/30/2008","primary_completion_date":" 12/30/2008","study_txt":" Completion: 12/30/2008","study_completion_date":" 12/30/2008","last_update_posted":"2023-10-24"},{"id":"5f33b52c-f869-48bf-bc7e-d225940640d4","acronym":"","url":"https://clinicaltrials.gov/study/NCT00096161","created_at":"2021-01-18T00:17:58.402Z","updated_at":"2024-07-02T16:36:50.637Z","phase":"Phase 2","brief_title":"Pentostatin and Lymphocyte Infusion in Preventing Graft Rejection in Patients Who Have Undergone Donor Stem Cell Transplant","source_id_and_acronym":"NCT00096161","lead_sponsor":"Fred Hutchinson Cancer Center","biomarkers":" HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C","pipe":"","alterations":" ","tags":["HLA-DRB1 • HLA-DQB1 • HLA-B • HLA-C"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e cyclosporin A microemulsion • pentostatin"],"overall_status":"Completed","enrollment":" Enrollment 36","initiation":"Initiation: 05/01/2003","start_date":" 05/01/2003","primary_txt":" Primary completion: 02/01/2015","primary_completion_date":" 02/01/2015","study_txt":" Completion: 08/01/2015","study_completion_date":" 08/01/2015","last_update_posted":"2020-01-31"}]